Advertisement

Topics

Nightingale Health Obtains CE Mark for Blood Analysis Platform

12:33 EDT 3 Jul 2017 | HIT Consultants

Finnish biomedical startup Nightingale Health has obtained CE marking for its blood biomarker analysis platform. The CE mark enables the clinical use of the analysis service and the analysed measures of creatinine and glucose in the EU region. Nightingale Health’s blood biomarker analysis platform is based on NMR (Nuclear Magnetic Resonance) spectroscopy. It captures over ... Read More

Original Article: Nightingale Health Obtains CE Mark for Blood Analysis Platform

NEXT ARTICLE

More From BioPortfolio on "Nightingale Health Obtains CE Mark for Blood Analysis Platform"

Advertisement
Quick Search
Advertisement
Advertisement